Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases-Reference-Cited by-同舟云学术

Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases

Published:2000-10-01 Issue:10 Volume:39 Page:1089-1094
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Liozon E.,Roblot P.,Paire D.,Loustaud V.,Liozon F.,Vidal E.,Jauberteau M. O.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/39/10/1089/5044933/391089.pdf

Reference39 articles.

1. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica

2. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases

3. Anticardiolipin antibodies and giant cell arteritis: A prospective, multicenter case-control study

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapses in giant cell arteritis: Updated review for clinical practice;Autoimmunity Reviews;2024-06

2. Current Insights into Tissue Injury of Giant Cell Arteritis: From Acute Inflammatory Responses towards Inappropriate Tissue Remodeling;Cells;2024-02-29

3. Giant-cell arteritis related strokes: scoping review of mechanisms and rethinking treatment strategy?;Frontiers in Neurology;2023-12-07

4. Development of outcome measures for giant cell arteritis for use in clinical trials and standard practice;Clinical Rheumatology;2023-07-19

5. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?;Frontiers in Immunology;2023-06-15